Polyglandular autoimmune syndrome in adults: molecular genetic and clinical characteristics (lecture)

Cover Page

Cite item

Full Text

Abstract

Endocrine system disorders (diabetes mellitus, thyroid gland pathologies, polyglandular autoimmune syndromes, adrenal insufficiency, autoimmune ophthalmopathy and others) in development of which immune response disorders play an important role are among the most severe chronic human diseases prevention and early diagnostics of which are often hampered by disease clinical course latent phases. Polyglandular autoimmune syndromes (PAS) comprise damage of two or more endocrine glands characterized with multiple organ failure. In Russian classification the syndrome is divided into 2 main subtypes: PAS type 1 (the prevalence varies from 1:9 thousands to 1 per 200 thousands population) and PAS type 2 (the prevalence is 1.4-4.5 cases per 100 thousands population). Other classifications comprise hidden (latent and potential) forms of the disorder. Patients with PAS are a special cohort that requires careful monitoring and regular screening for prognosis and detection of new components of PAS. High prevalence and incidence rates, disabling complications, and reproductive losses - all of these are common in autoimmune endocrinopathies and are an important challenge at present. The lecture summarizes key clinical and diagnostic characteristics of PAS, proposes practical approach to these syndromes treatment, and specifies key laboratory markers for the disorder dynamics monitoring.

About the authors

Ekaterina A. Troshina

Endocrinology Research Centre

Email: *troshina@inbox.ru
Corr. Memb. RAS, D. Sci. (Med.), Full Prof. Moscow, Russia

Anna A. Larina

Endocrinology Research Centre

Endocrinologist Moscow, Russia

Maria A. Terekhova

I.M. Sechenov First Moscow State Medical University (Sechenov University)

student Moscow, Russia

References

  1. Neufeld M, Blizzard R.M. Polyglandular autoimmune diseases. In: Pinchera A, Doniach D, Fenzi G.F, Baschieri L, ed. Symposium on Autoimmune Aspects of Endocrine Disorders. New York: Academic Press, 1980; p. 357-65.
  2. Gombos Z, Hermann R, Kiviniemi M et al. Analysis of extended human leukocyte antigen haplotype association with Addison's disease in three populations. Eur J Endocrinol 2007; 157: 757-61.
  3. Hansen M.P, Kahaly G.J. Autoimmune polyglandular syndromes Dtsch Med Wochenschr 2013; 138 (7): 319-26; quiz 327-8. doi: 10.1055/s-0032-1327355
  4. Kahaly G.J. Polyglandular autoimmune syndromes. Eur J Endocrinol 2009; 161 (1): 11-20.
  5. Betterle C, Lazzarotto F, Presotto F. Autoimmune polyglandular syndrome Type 2: the tip of an iceberg? Clin Exp Immunol 2004; 137 (2): 225-33.
  6. Diagnostic criteria in autoimmune diseases. Y Shoenfeld, R Cervera, ME Gershwin, eds. Humana Press, Totowa, NJ. 2008.
  7. Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune Adrenal Insufficiency and Autoimmune Polyendocrine Syndromes: Autoantibodies, Autoantigens, and Their Applicability in Diagnosis and Disease Prediction. Endocr Rev 2002; 23 (3): 327-64. https://doi.org/10.1210/edrv.23.3.0466
  8. Betterle C, Volpato M, Greggio A.N., Presotto F. Type 2 polyglandular autoimmune disease (Schmidt's syndrome). J Pediatr Endocrinol Metab 1996; 9 (1): 113-23.
  9. Albergoni P, Gazzola M.V, Slanzi E et al. HLA-DR and DQ associations with autoimmune Addison's disease in Italian patients. Genes Immunity 2003; 4 (1): S35.
  10. Betterle C, Zanchetta R. Update on autoimmune polyendocrine syndromes (APS). Clinical Immunology and Allergology. Acta Bio Medica 2003; 74: 9-33.
  11. Golden B, Levin L, Ban Y et al. Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes. J Clin Endocrinol Metab 2005; 90 (8): 4904-11.
  12. Kahaly G.J, Frommer L, Schuppan D. Celiac Disease and Glandular Autoimmunity. Nutrients 2018; 10 (7): 814. doi: 10.3390/nu10070814
  13. Fan K.C, Yang T.H, Huang Y.C. Vitiligo and thyroid disease: a systematic review and meta-analysis. Eur J Dermatol 2018; 28 (6): 750-63. doi: 10.1684/ejd.2018.3449.
  14. Vrijman C, Kroon M.W, Limpens J et al. The prevalence of thyroid disease in patients with vitiligo: a systematic review. Br J Dermatol 2012; 167 (6): 1224-35. doi: 10.1111/j.1365-2133
  15. Klein J, Stato A. The HLA System. First of two Parts. N Engl J Med 2000; 343: 702-9.
  16. Klein J, Stato A. The HLA System. Second of two Parts. N Engl J Med 2000; 343: 782-6.
  17. Huang W, Connor E, Dela Rosa T et al. Although DR3-DQB1*0201 may be associated with multiple component diseases of the Autoimmune Polyglandular Syndrome, the Human Leukocyte Antigen DR4-DQB1*0302 haplotype is implicated only in beta-cells autoimmunity. J Clin Endocrinol Metab 1996; 81: 2259-63.
  18. Erichsen M, Løvås K, Skinningsrud B et al. Clinical, Immunological, and Genetic Features of Autoimmune Primary Adrenal Insufficiency: Observations from a Norwegian Registry. J Clin Endocrinol Metab 2009; 94 (12): 4882-90.
  19. Flesch B.K, Matheis N, Alt T et al. HLA class II haplotypes differentiate between the adult autoimmune polyglandular syndrome types II and III. J Clin Endocrinol Metab 2014; 99 (1): E177-82. doi: 10.1210/jc.2013-2852
  20. Triolo T.M, Baschal E.E, Armstrong T.K et al. Homozygosity of the Polymorphism MICA5.1 Identifies Extreme Risk of Progression to Overt Adrenal Insufficiency among 21-Hydroxylase Antibody-Positive Patients with Type 1 Diabetes. J Clin Endocrinol Metab 2009; 94 (11): 4517-23.
  21. Huber A, Menconi F, Corathers S et al. Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev 2008; 29: 697-725.
  22. Villano M.J.B, Huber A.K, Greenberg D.A et al. Autoimmune thyroiditis and diabetes: dissecting the joint genetic susceptibility in a large cohort of multiplex families. J Clin Endocrinol Metab 2009; 94: 1458-66.
  23. Houcken J, Degenhart C, Bender K et al. PTPN22 and CTLA-4 Polymorphisms Are Associated With Polyglandular Autoimmunity. J Clin Endocrinol Metab 2018; 103 (5): 1977-84. doi: 10.1210/jc.2017-02577
  24. Dultz G, Matheis N, Dittmar M et al. CTLA-4 CT60 polymorphism in thyroid and polyglandular autoimmunity. Horm Metab Res 2009; 41 (6): 426-9.
  25. Skinningsrud B, Husebye E.S, Gervin K et al. Mutation screening of PTPN22: association of the 1858T-allele with Addison's disease. Eur J Human Genetics 2008; 16: 977-82.
  26. Никонова Т.В. Сахарный диабет 1 типа и латентный аутоиммунный диабет взрослых (LADA): клинические, иммуно-генетические и гормонально-метаболические аспекты. Автореф. дис.. д-ра мед. наук. М., 2011.
  27. Owen C.J, Eden J.A, Jennings C.E et al. Genetic association studies of the FOXP3 gene in Graves' disease and autoimmune Addison's disease in the United Kingdom population. J Mol Endocrinol 2006; 37 (1): 97-104.
  28. Lopez E.R, Lange B, Kahles H et al. Insulin gene polymorphisms in type 1 diabetes, Addison's disease and the polyglandular autoimmune syndrome type II. BMC Med Genet 2008; 9: 65.
  29. Lopez E.R, Zwermann O, Segni M et al. A promoter polymorphism of the CYP27B1 gene is associated with Addison's disease, Hashimoto's thyroiditis, Graves' disease and type 1 diabetes mellitus in Germans. Eur J Endocrinol 2004; 151 (2): 193-7

Copyright (c) 2019 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies